Detalles de la búsqueda
1.
A Phase 2b, Randomized, Double-blind, Placebo-Controlled Multicenter Study Evaluating Antiviral Effects, Pharmacokinetics, Safety, and Tolerability of Presatovir in Hematopoietic Cell Transplant Recipients with Respiratory Syncytial Virus Infection of the Lower Respiratory Tract.
Clin Infect Dis
; 71(11): 2787-2795, 2020 12 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-31915807
2.
A Phase 2, Randomized, Double-blind, Placebo-Controlled Trial of Presatovir for the Treatment of Respiratory Syncytial Virus Upper Respiratory Tract Infection in Hematopoietic-Cell Transplant Recipients.
Clin Infect Dis
; 71(11): 2777-2786, 2020 12 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-31793991
3.
Efficacy and Safety of Filgotinib for the Treatment of Perianal Fistulising Crohn's Disease [DIVERGENCE 2]: A Phase 2, Randomised, Placebo-controlled Trial.
J Crohns Colitis
; 18(6): 864-874, 2024 Jun 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-38366672
4.
Fosfomycin and tobramycin in combination downregulate nitrate reductase genes narG and narH, resulting in increased activity against Pseudomonas aeruginosa under anaerobic conditions.
Antimicrob Agents Chemother
; 57(11): 5406-14, 2013 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-23959314
5.
A randomized controlled trial of presatovir for respiratory syncytial virus after lung transplant.
J Heart Lung Transplant
; 42(7): 908-916, 2023 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-36964084
6.
Midturbinate Swabs Are Comparable to Nasopharyngeal Swabs for Quantitative Detection of Respiratory Syncytial Virus in Infants.
J Pediatric Infect Dis Soc
; 8(6): 554-558, 2019 Dec 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-30462262
7.
Andecaliximab [Anti-matrix Metalloproteinase-9] Induction Therapy for Ulcerative Colitis: A Randomised, Double-Blind, Placebo-Controlled, Phase 2/3 Study in Patients With Moderate to Severe Disease.
J Crohns Colitis
; 12(9): 1021-1029, 2018 Aug 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-29767728
8.
A Phase 2, Randomized, Placebo-Controlled Study Evaluating Matrix Metalloproteinase-9 Inhibitor, Andecaliximab, in Patients With Moderately to Severely Active Crohn's Disease.
J Crohns Colitis
; 12(9): 1014-1020, 2018 Aug 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-29846530
9.
Resistance development of cystic fibrosis respiratory pathogens when exposed to fosfomycin and tobramycin alone and in combination under aerobic and anaerobic conditions.
PLoS One
; 8(7): e69763, 2013.
Artículo
en Inglés
| MEDLINE | ID: mdl-23936095
10.
Antimicrobial activity of fosfomycin and tobramycin in combination against cystic fibrosis pathogens under aerobic and anaerobic conditions.
J Cyst Fibros
; 11(3): 163-72, 2012 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-22138067
Resultados
1 -
10
de 10
1
Próxima >
>>